Original Research
Published on 18 Jul 2011
Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2011.00036
- 6,826 views
- 33 citations